宫颈癌治疗性疫苗研究现状及进展
Current Status and Progress inDeveloping Therapeutic CervicalCancer Vaccines
出处
《实用妇产科杂志》
CAS
CSCD
北大核心
2010年第3期161-167,共7页
Journal of Practical Obstetrics and Gynecology
基金
Queensland Government Premiers Fellowship
Research funding from the National Health of Australia
Medical Research Foundation of Australia
The Cancer Council Australia
The Wellcome Trust
The Cancer Research Institute
New York
参考文献56
-
1Sophie Hallez,Philippe Simon,Frédéric Maudoux,Jean Doyen,Jean-Christophe No?l,Aude Beliard,Xavier Capelle,Frédéric Buxant,Isabelle Fayt,Anne-Cécile Lagrost,Pascale Hubert,Colette Gerday,Arsène Burny,Jacques Boniver,Jean-Michel Foidart,Philippe Delvenne,Nathalie Jacobs.Phase I/II trial of immunogenicity of a human papillomavirus (HPV) type 16 E7 protein–based vaccine in women with oncogenic HPV-positive cervical intraepithelial neoplasia[J]. Cancer Immunology, Immunotherapy . 2004 (7)
-
2Alfonso Ferrara,Marion Nonn,Peter Sehr,Carola Schreckenberger,Michael Pawlita,Matthias Dürst,Achim Schneider,Andreas M. Kaufmann.Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients[J]. Journal of Cancer Research and Clinical Oncology . 2003 (9)
-
3Stephen E. Goldstone M.D.,Joel M. Palefsky M.D.,Mark T. Winnett B.S.,John R. Neefe M.D..Activity of HspE7, a Novel Immunotherapy, in Patients with Anogenital Warts[J]. Diseases of the Colon & Rectum . 2002 (4)
-
4Kenter GG,,Welters MJ,Valentijn AR,et al.Vaccination against HPV-16oncoproteins for vulvar intraepithelial neoplasia. The New England Journal of Medicine . 2009
-
5Vajdic CM,van Leeuwen MT.Cancer incidence and risk factors after solid organ transplantation. International Journal of Cancer . 2009
-
6Wang SS,Zuna RE,Wentzensen N,et al.Human papillomavirus co-factors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiology Biomarkers and Prevention . 2009
-
7Wang SS,Bratti MC,Rodriguez AC,et al.Common variants in im-mune and DNA repair genes and risk for human papillomavirus per-sistence and progression to cervical cancer. The Journal of Infectious Diseases . 2009
-
8Olsson SE,Kjaer SK,Sigurdsson K,et al.Evaluation of quadrivalent HPV6/11/16/18vaccine efficacy against cervical and anogenital dis-ease in subjects with serological evidence of prior vaccine type HPV infection. Hum Vaccin . 2009
-
9Jochmus-Kudielka I,,Schneider A,Braun R,et al.Antibodies a-gainst the human papillomavirus type16early proteins in human sera:Correlation of anti-E7reactivity with cervical cancer. Journal of the National Cancer Institute . 1989
-
10van den Hende M,Van Poelgeest MI,Van der Hulst JM,et al.Skin reactions to human papillomavirus(HPV)16specific antigens intra-dermally injected in healthy subjects and patients with cervical neo-plasia. International Journal of Cancer . 2008
-
1朱崇云,尤丛兰.奥平栓治疗宫颈糜烂196例分析[J].中国实用乡村医生杂志,2004,11(2):29-29.
-
2唐良萏,冷若冰.人乳头瘤病毒疫苗的临床应用[J].实用妇产科杂志,2013,29(3):172-174. 被引量：11
-
3彭琦,洪颖.阴道上皮内瘤变诊治的研究进展[J].中国妇幼健康研究,2014,25(2):341-343. 被引量：1
-
4田厚文,冯靖.人乳头瘤病毒治疗性疫苗及应用前景[J].中国实用妇科与产科杂志,2010,26(5):336-340. 被引量：9
-
5杨菊芳,谢红,王莉菲,马利国,张琳.高频电波刀干扰素栓联合治疗宫颈持续性高危型HPV感染[J].中国妇幼保健,2011,26(13):2044-2047. 被引量：9
-
6许丹,张玉泉.HPV疫苗防治宫颈癌的研究进展[J].现代妇产科进展,2007,16(2):137-139. 被引量：9
-
7林蓓.人乳头瘤病毒疫苗的研究与临床应用[J].中国实用妇科与产科杂志,2010,26(3):190-192. 被引量：5
-
8刘琴.外阴尖锐湿疣的诊断和治疗[J].黑龙江大学自然科学学报,1998,15(3):104-105.
-
9刘菲,王承伟.促黄体生成激素水平诊断继发性闭经的意义[J].中国妇幼保健,2013,28(3):423-424. 被引量：1
-
10刘昱,赵丽君,魏丽惠.宫颈癌治疗性HPV疫苗的研究进展[J].现代妇产科进展,2013,22(9):767-769. 被引量：6
